HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Wu Selected Research

Cytokines

2/2021Gene polymorphisms of pro-inflammatory cytokines may affect the risk of Graves' disease: a meta-analysis.
11/2018A preliminary study on topical ozonated oil in the therapeutic management of atopic dermatitis in murine.
9/2015miR-509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF-α.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Wu Research Topics

Disease

29Neoplasms (Cancer)
03/2024 - 04/2000
10Stomach Neoplasms (Stomach Cancer)
01/2022 - 02/2001
9Infections
02/2024 - 09/2000
9Neoplasm Metastasis (Metastasis)
01/2022 - 10/2001
7Carcinoma (Carcinomatosis)
10/2020 - 02/2000
6Carcinogenesis
03/2012 - 04/2000
5Breast Neoplasms (Breast Cancer)
09/2015 - 03/2000
3Tongue Neoplasms (Tongue Neoplasm)
03/2024 - 10/2022
3Hemorrhage
01/2022 - 04/2007
3Adenoma (Adenomas)
01/2016 - 02/2001
3Colorectal Neoplasms (Colorectal Cancer)
03/2012 - 09/2002
2Lymphatic Metastasis
03/2024 - 04/2016
2Cardiovascular Diseases (Cardiovascular Disease)
06/2023 - 10/2005
2Hematoma
10/2022 - 12/2021
2Hepatocellular Carcinoma (Hepatoma)
05/2020 - 02/2006
2Psoriasis (Pustulosis Palmaris et Plantaris)
01/2019 - 10/2000
2Mouth Neoplasms (Oral Cancer)
01/2019 - 02/2016
2Birth Weight (Birth Weights)
01/2019 - 09/2017
2Body Weight (Weight, Body)
03/2017 - 12/2013
2Hypoxia (Hypoxemia)
01/2016 - 05/2008
2Renal Cell Carcinoma (Grawitz Tumor)
01/2016 - 04/2013
2Hypertension (High Blood Pressure)
12/2015 - 07/2014
2Prostatic Neoplasms (Prostate Cancer)
10/2015 - 04/2014
2Necrosis
05/2013 - 07/2010
2Leukemia
04/2013 - 08/2001
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2013 - 06/2012
2Ulcerative Colitis
11/2012 - 02/2010
2Coronary Disease (Coronary Heart Disease)
04/2009 - 10/2005
2Stroke (Strokes)
10/2005 - 03/2000
2Temporal Lobe Epilepsy
01/2003 - 01/2001
2Seizures (Absence Seizure)
01/2003 - 01/2001
2Atrophy
06/2002 - 12/2001
1Diarrhea
01/2023
1Wound Infection (Wound Infections)
10/2022
1Virus Diseases (Viral Diseases)
10/2022
1Overweight
09/2022
1Intestinal Obstruction (Obstruction, Intestinal)
01/2022
1Anemia
01/2022
1Hypoalbuminemia
01/2022
1Gastroparesis
01/2022
1Adenocarcinoma
01/2022
1Pleural Effusion (Pleural Effusions)
01/2022
1Anastomotic Leak
01/2022
1Wounds and Injuries (Trauma)
01/2022
1Chronic Subdural Hematoma
12/2021

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
05/2020 - 02/2000
6Small Interfering RNA (siRNA)IBA
09/2015 - 01/2005
5Biomarkers (Surrogate Marker)IBA
09/2015 - 01/2008
4Messenger RNA (mRNA)IBA
04/2016 - 04/2000
4MicroRNAs (MicroRNA)IBA
09/2015 - 10/2010
3Phosphotransferases (Kinase)IBA
02/2024 - 05/2008
3Insulin (Novolin)FDA Link
02/2024 - 03/2013
3CytokinesIBA
02/2021 - 09/2015
3Cadherins (E-Cadherin)IBA
02/2020 - 02/2006
3ORALIT (ORS)IBA
09/2017 - 01/2008
3EnzymesIBA
08/2017 - 09/2000
3Sirolimus (Rapamycin)FDA Link
08/2015 - 07/2011
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2014 - 10/2001
3alpha-TocopherolFDA Link
02/2001 - 05/2000
2pazopanibFDA Link
01/2023 - 04/2013
2Interleukin-1 (Interleukin 1)IBA
02/2021 - 06/2002
2Interleukin-6 (Interleukin 6)IBA
02/2021 - 05/2013
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2021 - 07/2010
2Oxygen (Dioxygen)IBA
01/2019 - 12/2004
2AntigensIBA
08/2017 - 02/2006
2AndrogensIBA
01/2016 - 10/2015
2RNA (Ribonucleic Acid)IBA
09/2015 - 02/2001
2Transcription Factors (Transcription Factor)IBA
12/2014 - 05/2008
2Sorafenib (BAY 43-9006)FDA Link
07/2014 - 04/2013
2Infliximab (Remicade)FDA Link
11/2012 - 02/2010
2N- (3- aminopropyl)- N- (1- (5- benzyl- 3- methyl- 4- oxo- (1,2)thiazolo(5,4- d)pyrimidin- 6- yl)- 2- methylpropyl)- 4- methylbenzamideIBA
06/2012 - 01/2012
2Fibrinogen (Factor I)FDA Link
04/2009 - 10/2005
2IodineIBA
01/2008 - 05/2007
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
06/2007 - 12/2006
2ArsenicIBA
03/2007 - 06/2001
2Laminin (Merosin)IBA
01/2005 - 02/2001
2Urethane (Ethyl Carbamate)IBA
01/2003 - 01/2001
2Kainic Acid (Kainate)IBA
01/2003 - 01/2001
2Monoclonal AntibodiesIBA
09/2002 - 11/2001
1Transforming Growth Factors (Transforming Growth Factor)IBA
02/2024
1Phosphatidylinositols (Phosphatidylinositol)IBA
02/2024
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
02/2024
1Rosiglitazone (Avandia)FDA Link
06/2023
1Free RadicalsIBA
10/2022
1AntioxidantsIBA
10/2022
1insulin receptor-related receptor (IRR)IBA
09/2022

Therapy/Procedure

12Therapeutics
11/2019 - 11/2001
3Aftercare (After-Treatment)
01/2017 - 07/2001
3Transplantation
12/2016 - 01/2008
2Lymph Node Excision (Lymph Node Dissection)
03/2024 - 10/2022
2Neck Dissection (Radical Neck Dissection)
03/2024 - 10/2017
2Glossectomy
07/2023 - 10/2022
2Free Tissue Flaps
10/2022 - 02/2016
2Radiotherapy
06/2019 - 10/2000
2Lasers (Laser)
01/2016 - 08/2014
1Oral Surgery (Maxillofacial Surgery)
10/2022
1Conservative Treatment
01/2022
1Hyperthermic Intraperitoneal Chemotherapy
01/2022
1Gastrectomy
01/2022
1Perioperative Period
01/2022